£16.0M
The investment will fund UK commercial rollout and US regulatory approval for the company's remote patient monitoring platform.
Entia develops remote patient monitoring and blood testing technology for cancer treatment.
Entia develops remote patient monitoring technology and predictive analytics to support individuals undergoing cancer treatment. The company combines at-home blood testing with digital solutions to provide personalised health insights.
Toby Basey-Fisher
CEO and Founder
The investment will fund UK commercial rollout and US regulatory approval for the company's remote patient monitoring platform.
The investment round was led by BGF with participation from Parkwalk and Sussex Place Ventures.